NCT02507583 2025-05-07
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Thomas Jefferson University
Phase 1 Completed
Clinical Trials
7 trialsNCT00293423 2021-05-13
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
University of California, San Francisco
Phase 1/2 Completed
NCT00905060 2021-03-24
HeatShock
University of California, San Francisco
Phase 2 Completed
NCT00805376 2018-07-16
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas
DNAtrix, Inc.
Phase 1 Completed
NCT01644955 2018-07-02
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT02092038 2015-11-10
Preoperative Chemoradiation for Glioblastoma
Tampa General Hospital
Phase 1 Completed
NCT00075166 2008-03-04
Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 4 Completed